United States Biopsy Market, Volume & Segments, Forecast 2019-2025 - PowerPoint PPT Presentation

About This Presentation
Title:

United States Biopsy Market, Volume & Segments, Forecast 2019-2025

Description:

According to Renub Research United States Biopsy Market is expected to cross US$ 14 Billion mark by the end of the year 2025. Volume & Segments, Forecast 2019-2025 – PowerPoint PPT presentation

Number of Views:53

less

Transcript and Presenter's Notes

Title: United States Biopsy Market, Volume & Segments, Forecast 2019-2025


1
United States Biopsy Market
United States Biopsy Market
2
Report Description and Highlights
The biopsy is the procedure to collect the
tissues or fluid from the area, which has grown
abnormally over a period of time. The sample
(tissue or fluid) is further examined through the
microscope to check the presence of cancer.
Different types of biopsy are done to know
cancer, such as vacuum-assisted biopsy,
fine-needle aspiration biopsy, and core needle
biopsy. For colorectal cancer, colonoscopy or
endoscopy is primarily done to check
abnormalities, and during the process, abnormal
tissues called polyps would collect for biopsy.
In the United States, overall cancer incidence is
rising, but the cancer death rate is falling over
the period of time because of the rise in the
number of cancer diagnostics, especially biopsy
screening for cancer. United States Biopsy Market
is expected to cross US 14 Billion mark by the
end of the year 2025.
United States Biopsy Market
3
United States Biopsy Market
The essential factors that will fuel the market
growth are the rise of an ageing population in
the United States, continuous improvement of
healthcare infrastructure, rising per capita
health care expenditure, increasing per capita
income, growing awareness about early detection
of cancer by several screening including biopsy,
improvement of diagnostic technologies, etc.
Moreover, the rising incidence of cancer in the
United States and increase of less invasive
procedures during biopsy will further propel the
United States biopsy market in the future course
of time. Renub Research report titled United
States Biopsy Market, Volume Forecast by
Segments (Breast, Prostate, Lung, Liver ,Thyroid,
Kidney, Colorectal and Skin) Cancer, Companies
(C. R. Bard, Inc., Becton, Dickinson and Company,
B. Braun Melsungen AG, Cardinal Health, Inc.,
Olympus Corporation, FUJIFILM Holdings
Corporation, Medtronic plc., Hologic,
Inc) provides a complete analysis of the United
States Biopsy Market and Volume.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
lunited-states-biopsy-testing-market-and-volume-a
nalysis-to-2020-511-p.php
United States Biopsy Market
4
United States Biopsy Market
United States Biopsy Volume Insights - Breast
Cancer Biopsy is holding the largest Volume
Share In this report, we have fragmented cancer
by biopsy volume into 8 parts Breast Cancer,
Prostate Cancer, Lung Cancer, Liver Cancer,
Thyroid Cancer, Kidney Cancer, Colorectal Cancer,
and Skin Cancer. Breast cancer biopsy is holding
the largest volume share of cancer biopsy in the
United States. This report provides a multifactor
analysis of why biopsy volume is rising in the
United States. United States Biopsy Market
Insights In this report, we have categorized the
biopsy market into 8 parts by cancer type Breast
Cancer, Prostate Cancer, Lung Cancer, Liver
Cancer, Thyroid Cancer, Kidney Cancer, Colorectal
Cancer, and Skin Cancer. For many cancer, more
than one biopsy is required to diagnose the
patients like colorectal cancer requires at least
6 biopsies. Besides, we have also explained the
growth driver and challenges of the biopsy market
in the United States.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urlunited-states-biopsy-testing-market-and-volume
-analysis-to-2020-511-p.php
United States Biopsy Market
5
United States Biopsy Market
United States New Cases of Cancer Diagnostic
Insights In this report, we have shown new
cancer diagnostic cases and also providing the
factor by which cancer prevalence is increasing
or decreasing over a period of time. Segments
Covered in the Report     Breast Cancer
Biopsy     Prostate Cancer Biopsy    Lung
Cancer Biopsy     Liver Cancer Biopsy  
 Thyroid Cancer Biopsy     Kidney Cancer
Biopsy    Colorectal Cancer Biopsy     Skin
Cancer Biopsy Key Companies Covered in the
Report     C. R. Bard, Inc.     Becton,
Dickinson and Company    B. Braun Melsungen
AG     Cardinal Health, Inc.    Olympus
Corporation     FUJIFILM Holdings
Corporation    Medtronic plc.     Hologic,
Inc
United States Biopsy Market
6
United States Biopsy Market
Forecast for United States Biopsy Market Share
() - by Segments (2019 - 2025)
Source Renub Research Analysis Note
These are dummy figures actual data given in the
report
United States Biopsy Market
7
United States Biopsy Market
Browse Related Report Autoimmune Disease
Diagnostic Market France In-Vitro Diagnostics
(IVD) Market Contact Us Tel 1-678-302-0700
(US), 91-120-421-9822 (INDIA) Email
info_at_renub.com
United States Biopsy Market
Write a Comment
User Comments (0)
About PowerShow.com